BOCKORNY GROUP, INC. for CVS HEALTH INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2024 | $50,000 | Replaced |
| 4th Quarter - Termination | Jan 23, 2024 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to drug pricing Issues related to health reform proposals Issues related to representation in COVID-19-related packages HR 1770 - Equitable Community Access to Pharmacist Services Act Issues related to Pharmacy Benefit Managers
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY MAXWELL BECKER | — |
| DAVID BOCKORNY | — |
| MARTIN DEPOY | — |
Budget/Appropriations BUD
Issues related to hospital payments Issues related to hospital inclusion and representation in COVID-19 packages; HR 1770 Public Law Number 116-136 CARES Act H.R. 1868 An Act to prevent across-the-board direct spending cuts, and for other purposes
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY MAXWELL BECKER | — |
| DAVID BOCKORNY | — |
| MARTIN DEPOY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.